GSK agreed to acquire Chimagen Biosciences, according to source material published on September 18, 2026. The reported purchase consideration is $750,000,000. This summary is limited to the approved transaction facts in the cited source evidence.
GSK agreed to acquire Chimagen Biosciences
GSK agreed to acquire Chimagen Biosciences
AcquisitionUSD750,000,000Technology, Information and Media
Get the full Chimagen Biosciences company profile
Access contacts, investors, buying signals & more
Acquired
Chimagen Biosciences
Technology, Information and Media
Deal value
USD750,000,000
September 18, 2026
Acquirer
GSK
Pharmaceutical Manufacturing
Unlock GTM signals
Discover Chimagen Biosciences's tech stack and active buying intent.
Unlock key decision-makers
Get direct access to the decision-makers at Chimagen Biosciences.